- Sunfield Clinic
- Sunfield Clinic
Sanfield Clinic is a medical institution that has acquired a regenerative medicine provision plan number and has been providing stem cell therapy
since 2011.
- Sunfield Clinic
- Sunfield Clinic
Sanfield Clinic is a medical institution that has acquired a regenerative medicine provision plan number and has been providing stem cell therapy
since 2011.
Concept
Sanfield Clinic is a medical institution that has acquired a regenerative medicine provision plan number and has been providing stem cell therapy since 2012.
Medical institutions that provide regenerative medicine using stem cells must create a regenerative medicine provision plan for each regenerative medical technique they implement, and undergo a review of safety, effectiveness, etc. by the Specially Certified Regenerative Medicine Committee, approved by the Ministry of Health, Labour and Welfare. Sunfield Clinic is a medical institution that has submitted an approved regenerative medicine plan to the Ministry of Health, Labour and Welfare and obtained a Type 2 regenerative medicine provision plan number.
□ Regenerative medicine, etc. provided: “Autologous adipose-derived mesenchymal stem cell therapy for the prevention of the progression of arteriosclerosis”
(Classification of regenerative medicine, etc.: Type 2, Plan number PB3230222)
□ Regenerative medicine, etc. provided: “Autologous adipose-derived mesenchymal stem cell therapy for the relief of chronic pain”
(Classification of regenerative medicine, etc.: Type 2, Plan number PB3230228)
(Classification of regenerative medicine, etc.: Type 2, Plan number PB3230222)
□ Regenerative medicine, etc. provided: “Autologous adipose-derived mesenchymal stem cell therapy for the relief of chronic pain”
(Classification of regenerative medicine, etc.: Type 2, Plan number PB3230228)
Potential for treatment using stem cell therapy
□ Regenerative medicine, etc. provided: “Autologous adipose-derived mesenchymal stem cell therapy for the prevention of the progression of arteriosclerosis”
(Classification of regenerative medicine, etc.: Type 2, Plan number PB3230222)
□ Regenerative medicine, etc. provided: “Autologous adipose-derived mesenchymal stem cell therapy for the relief of chronic pain”
(Classification of regenerative medicine, etc.: Type 2, Plan number PB3230228)
(Classification of regenerative medicine, etc.: Type 2, Plan number PB3230222)
□ Regenerative medicine, etc. provided: “Autologous adipose-derived mesenchymal stem cell therapy for the relief of chronic pain”
(Classification of regenerative medicine, etc.: Type 2, Plan number PB3230228)
Treatment
Treatment at our hospital
stem cell therapy
Stem cell-based regenerative medicine
Culture supernatant treatment
Regenerative medicine using culture supernatant
Aging care (infusion therapy/injections)
Various treatments including anti-aging prevention
Doctors
Doctor introduction
Keiji Tanigawa, Chairman
Graduated from the National Defense
Medical College Specialist of the Japan Surgical Society
Certified physician and specialist of the Japan Society of Gastroenterological Surgery
Medical College Specialist of the Japan Surgical Society
Certified physician and specialist of the Japan Society of Gastroenterological Surgery
Director Norio Kokubo
Graduated from Nippon Medical School,
Surgery specialist,
Primary Care Association instructor,
Dementia support physician
Surgery specialist,
Primary Care Association instructor,
Dementia support physician
Masayuki Sano, Director and Consulting Physician
Graduated from Nagoya University School of Medicine,
Specialist of the Japanese Surgical Society,
Academic Director of the NPO Association for the Promotion of Preventive Medicine and Alternative Medicine, Chairman of
the Japan Association of Occupational Physicians, Director of the International Food Science Association
Specialist of the Japanese Surgical Society,
Academic Director of the NPO Association for the Promotion of Preventive Medicine and Alternative Medicine, Chairman of
the Japan Association of Occupational Physicians, Director of the International Food Science Association
Hiroki Ota, Chief Advisor
(Head of Regenerative Medicine and Research)
(Head of Regenerative Medicine and Research)
Graduated from the
School of Medicine at the Jikei University School of Medicine, Doctor of Medicine. Certified surgeon and specialist by the Japan Surgical Society. Vascular specialist
by the Japanese Society of Vascular Surgery. Certified endovascular surgeon by the Japanese Society for Vascular Surgery. Thoracic aortic aneurysm stent graft instructor.
Abdominal aortic aneurysm stent graft instructor.
Jikei University School of Medicine, Center for Integrated Medical Sciences, Department of Regenerative Medicine Research (current position).
School of Medicine at the Jikei University School of Medicine, Doctor of Medicine. Certified surgeon and specialist by the Japan Surgical Society. Vascular specialist
by the Japanese Society of Vascular Surgery. Certified endovascular surgeon by the Japanese Society for Vascular Surgery. Thoracic aortic aneurysm stent graft instructor.
Abdominal aortic aneurysm stent graft instructor.
Jikei University School of Medicine, Center for Integrated Medical Sciences, Department of Regenerative Medicine Research (current position).
Introduction to the clinic
Learn more
Introduction to specific cell processing manufacturing facilities
(cell culture processing facilities)
Learn more